Please classify this clinical trial as a success (1), failure (0), or indeterminate (-1) based on the following classification system:


Classification System:
Success (1):
- Completed, Early positive outcome
- Completed, Positive outcome/primary endpoint(s) met

Failure (0):
- Terminated, Lack of efficacy
- Completed, Negative outcome/primary endpoint(s) not met
- Terminated, Safety/adverse effects
- Terminated, Poor enrollment

Indeterminate (-1):
- Completed, Outcome indeterminate
- Completed, Outcome unknown
- Terminated, Business decision - Drug strategy shift
- Terminated, Business decision - Other
- Terminated, Business decision - Pipeline reprioritization
- Terminated, Lack of funding
- Terminated, Other
- Terminated, Planned but never initiated
- Terminated, Unknown


Here is the trial information:

NCT ID: NCT00000143
Title: Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT)
Overall Status: COMPLETED
Phases: PHASE3
Enrollment: 61 (ACTUAL)

=== DETAILED OUTCOME MEASURES ===

1. PRIMARY OUTCOME: Survival
   Description: 
   Time Frame: 3 years
   Unit of Measure: participants
   Results:
      Results:
        Ganciclovir Implant and Oral Ganciclovir: 31
        Cidofovir IV (Intravenous): 30

=== ADVERSE EVENTS SUMMARY ===
Time Frame: 3 years

Group: Ganciclovir Implant and Oral Ganciclovir
  Serious Adverse Events: 0/31 participants (0.0%)
  Other Adverse Events: 0/31 participants (0.0%)

Group: Cidofovir IV (Intravenous)
  Serious Adverse Events: 0/30 participants (0.0%)
  Other Adverse Events: 0/30 participants (0.0%)

Based on the above detailed information, especially focusing on the statistical significance of outcomes, p-values, confidence intervals, and any adverse events, classify this trial as 1 (success), 0 (failure), or -1 (indeterminate). Return ONLY the classification number.